Endocan Corp Financials
| ENDO Stock | USD 0.0001 0.00 0.00% |
Endocan |
Understanding current and past Endocan Corp Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Endocan Corp's financial statements are interrelated, with each one affecting the others. For example, an increase in Endocan Corp's assets may result in an increase in income on the income statement.
Endocan Corp Stock Summary
Endocan Corp competes with Graphene Manufacturing, and 5E Advanced. Thermic Sciences International develops and sells hemp based products. Thermic Sciences International was incorporated in 1969 and is based in Colorado Springs, Colorado. ENDOCAN CORP operates under Specialty Chemicals classification in the United States and is traded on OTC Exchange.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| ISIN | US29271J1097 |
| Business Address | 2910 North Powers |
| Sector | Basic Materials |
| Industry | Specialty Chemicals |
| Benchmark | Dow Jones Industrial |
| Website | www.omnicanna.com |
| Phone | 888 263 0490 |
| Currency | USD - US Dollar |
Endocan Corp Key Financial Ratios
Endocan Corp's financial ratios allow both analysts and investors to convert raw data from Endocan Corp's financial statements into concise, actionable information that can be used to evaluate the performance of Endocan Corp over time and compare it to other companies across industries.Endocan Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Endocan Corp's current stock value. Our valuation model uses many indicators to compare Endocan Corp value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Endocan Corp competition to find correlations between indicators driving Endocan Corp's intrinsic value. More Info.Endocan Corp is rated as one of the top companies in current valuation category among its peers. It is rated # 5 in shares outstanding category among its peers creating about 36.23 of Shares Outstanding per Current Valuation. Comparative valuation analysis is a catch-all model that can be used if you cannot value Endocan Corp by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Endocan Corp's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Endocan Corp Systematic Risk
Endocan Corp's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Endocan Corp volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on Endocan Corp correlated with the market. If Beta is less than 0 Endocan Corp generally moves in the opposite direction as compared to the market. If Endocan Corp Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Endocan Corp is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Endocan Corp is generally in the same direction as the market. If Beta > 1 Endocan Corp moves generally in the same direction as, but more than the movement of the benchmark.
Other Information on Investing in Endocan Pink Sheet
Endocan Corp financial ratios help investors to determine whether Endocan Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Endocan with respect to the benefits of owning Endocan Corp security.